Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GETAFIX favipiravir trial in early COVID-19
ISRCTN31062548Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Sep 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of favipiravir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Disease severity up to day 15. Started Sep 2020; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN31062548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN31062548.